Sarcopenia in heart failure: a systematic review and meta‐analysis
Aims Sarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review an...
Saved in:
| Published in | ESC Heart Failure Vol. 8; no. 2; pp. 1007 - 1017 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
John Wiley & Sons, Inc
01.04.2021
John Wiley and Sons Inc Wiley |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Aims
Sarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta‐analysis to estimate the current overall prevalence of sarcopenia in patients with HF.
Methods and results
We searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random‐effects model. The Q test was used to assess the heterogeneity, and I2 statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full‐text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta‐analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22–47%, I2 = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I2 = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43–66%) for hospitalized patients with HF and 26% (95% CI: 16–37%) for ambulatory patients.
Conclusions
Sarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice. |
|---|---|
| AbstractList | Sarcopenia has been found to be frequently associated with co-morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta-analysis to estimate the current overall prevalence of sarcopenia in patients with HF.AIMSSarcopenia has been found to be frequently associated with co-morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta-analysis to estimate the current overall prevalence of sarcopenia in patients with HF.We searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random-effects model. The Q test was used to assess the heterogeneity, and I2 statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full-text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta-analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22-47%, I2 = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I2 = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43-66%) for hospitalized patients with HF and 26% (95% CI: 16-37%) for ambulatory patients.METHODS AND RESULTSWe searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random-effects model. The Q test was used to assess the heterogeneity, and I2 statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full-text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta-analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22-47%, I2 = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I2 = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43-66%) for hospitalized patients with HF and 26% (95% CI: 16-37%) for ambulatory patients.Sarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice.CONCLUSIONSSarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice. Aims Sarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta‐analysis to estimate the current overall prevalence of sarcopenia in patients with HF. Methods and results We searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random‐effects model. The Q test was used to assess the heterogeneity, and I2 statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full‐text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta‐analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22–47%, I2 = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I2 = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43–66%) for hospitalized patients with HF and 26% (95% CI: 16–37%) for ambulatory patients. Conclusions Sarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice. AimsSarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta‐analysis to estimate the current overall prevalence of sarcopenia in patients with HF.Methods and resultsWe searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random‐effects model. The Q test was used to assess the heterogeneity, and I2 statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full‐text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta‐analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22–47%, I2 = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I2 = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43–66%) for hospitalized patients with HF and 26% (95% CI: 16–37%) for ambulatory patients.ConclusionsSarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice. Abstract Aims Sarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta‐analysis to estimate the current overall prevalence of sarcopenia in patients with HF. Methods and results We searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random‐effects model. The Q test was used to assess the heterogeneity, and I2 statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full‐text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta‐analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22–47%, I2 = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I2 = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43–66%) for hospitalized patients with HF and 26% (95% CI: 16–37%) for ambulatory patients. Conclusions Sarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice. Sarcopenia has been found to be frequently associated with co-morbidity among patients with heart failure (HF). However, there remain insufficient data to accurately estimate the global prevalence of sarcopenia in HF. Therefore, the purpose of this research was to conduct a systematic review and meta-analysis to estimate the current overall prevalence of sarcopenia in patients with HF. We searched relevant databases for studies published up to 13 July 2020, assessing sarcopenia in vpatients with HF. After careful screening, data of included articles were extracted with a predesigned Excel form. Then the pooled prevalence of sarcopenia in patients with HF was calculated using the random-effects model. The Q test was used to assess the heterogeneity, and I statistic was calculated to quantify and evaluate the heterogeneity. Subgroup analyses were conducted to determine potential sources of heterogeneity. A total of 2852 articles were initially identified, and after removing duplicate publications and applying the selection criteria, we reviewed 79 full-text articles. Finally, 11 articles (n = 1742 patients with HF) were included in this systematic review and meta-analysis. The pooled prevalence of sarcopenia in patients with HF was 34% [95% confidence interval (CI): 22-47%, I = 96.59%] and ranged from 10% to 69%. However, substantial heterogeneity between studies (I = 96.59%, P < 0.001) was observed. There was no significant heterogeneity between subgroups by sex (P = 0.803) or the method used to define sarcopenia (P = 0.307). While the heterogeneity between subgroups by population setting was statistically significant (P < 0.001), the pooled prevalence of sarcopenia was 55% (95% CI: 43-66%) for hospitalized patients with HF and 26% (95% CI: 16-37%) for ambulatory patients. Sarcopenia was a common condition in patients with HF, and the prevalence of hospitalized patients was higher than for ambulatory patients. Early detection of sarcopenia was therefore important in patients with HF, and it was important to implement interventions so that physical therapists or managerial dieticians can easily be introduced into clinical practice. |
| Author | Ni, Wenqing Zhang, Hongmin Yuan, Xueli Li, Ping Xu, Jian Zhang, Yan Zhao, Zhiguang Zhang, Jia |
| AuthorAffiliation | 2 Administration Office Shenzhen Center for Chronic Disease Control Shenzhen Guangdong 518020 China 1 Department of Elderly Health Management Shenzhen Center for Chronic Disease Control Shenzhen Guangdong 518020 China |
| AuthorAffiliation_xml | – name: 2 Administration Office Shenzhen Center for Chronic Disease Control Shenzhen Guangdong 518020 China – name: 1 Department of Elderly Health Management Shenzhen Center for Chronic Disease Control Shenzhen Guangdong 518020 China |
| Author_xml | – sequence: 1 givenname: Yan orcidid: 0000-0002-4407-6686 surname: Zhang fullname: Zhang, Yan organization: Shenzhen Center for Chronic Disease Control – sequence: 2 givenname: Jia surname: Zhang fullname: Zhang, Jia organization: Shenzhen Center for Chronic Disease Control – sequence: 3 givenname: Wenqing surname: Ni fullname: Ni, Wenqing organization: Shenzhen Center for Chronic Disease Control – sequence: 4 givenname: Xueli surname: Yuan fullname: Yuan, Xueli organization: Shenzhen Center for Chronic Disease Control – sequence: 5 givenname: Hongmin surname: Zhang fullname: Zhang, Hongmin organization: Shenzhen Center for Chronic Disease Control – sequence: 6 givenname: Ping surname: Li fullname: Li, Ping organization: Shenzhen Center for Chronic Disease Control – sequence: 7 givenname: Jian orcidid: 0000-0001-5727-8191 surname: Xu fullname: Xu, Jian email: anniexu73@126.com organization: Shenzhen Center for Chronic Disease Control – sequence: 8 givenname: Zhiguang orcidid: 0000-0002-9901-0940 surname: Zhao fullname: Zhao, Zhiguang email: 1498384005@qq.com organization: Shenzhen Center for Chronic Disease Control |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33576177$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks9u1DAQxiNUREvphQdAkbggpC3-N47DoRIqLa1UiQNwtibOpOtVNl7spNXeeASekSfB221RW6HKB1szv_n0jWdeFjtDGKgoXnN2yBkTH2jeiUMuBcCzYk8wgBkYIXbuvXeLg5QWjDEOmoNQL4pdKaHSvKr2is_fMLqwosFj6YdyThjHskPfT5E-llimdRppiaN3ZaQrT9clDm25pBH__PqNA_br5NOr4nmHfaKD23u_-HF68v34bHbx9cv58aeLmdPMwKxydcNqAaRVVUuTD7WyazVy7JqmNa1Q6LLLzuUEtEZxIKNAyQYrDZWR-8X5VrcNuLCr6JcY1zagtzeBEC9ttu9dT9botjLcSdWAUgK0oYZcY-pWyw5r1mWto63WamqW1Doaxoj9A9GHmcHP7WW4soYxrWFj5t2tQAw_J0qjXfrkqO9xoDAlK5TJvUqlVEbfPkIXYYr58zIFwLPBCuTTFNNCaSMhU2_u-_5n-G6kGWBbwMWQUqTOOj_mAYZNG763nNnN4tjN4tibxckl7x-V3Kn-F-Zb-Nr3tH6CtCdnp2Jb8xeRz9Eb |
| CitedBy_id | crossref_primary_10_1016_j_archger_2024_105728 crossref_primary_10_3389_fcimb_2023_1127041 crossref_primary_10_4236_jbm_2025_132034 crossref_primary_10_1007_s00392_024_02571_7 crossref_primary_10_1016_j_ijcha_2024_101442 crossref_primary_10_12688_f1000research_125343_1 crossref_primary_10_1016_j_ihj_2022_12_004 crossref_primary_10_1038_s41598_024_80231_6 crossref_primary_10_1016_j_gerinurse_2023_07_003 crossref_primary_10_1093_ehjopen_oeae082 crossref_primary_10_1111_ggi_14736 crossref_primary_10_1097_CRD_0000000000000677 crossref_primary_10_1002_ehf2_14052 crossref_primary_10_3390_medicina60122017 crossref_primary_10_1007_s41999_022_00691_9 crossref_primary_10_1177_01939459241274869 crossref_primary_10_1016_j_numecd_2023_05_031 crossref_primary_10_1002_jpen_2635 crossref_primary_10_12677_ns_2024_1310202 crossref_primary_10_1016_j_cardfail_2024_08_049 crossref_primary_10_1016_j_jff_2022_104985 crossref_primary_10_3390_jpm12091453 crossref_primary_10_15829_1728_8800_2025_4230 crossref_primary_10_3390_biomedicines11092342 crossref_primary_10_3390_nu15102320 crossref_primary_10_3390_nu16010110 crossref_primary_10_1111_jgs_17160 crossref_primary_10_1016_j_numecd_2021_10_012 crossref_primary_10_30629_0023_2149_2023_101_6_286_292 crossref_primary_10_3390_nu16020236 crossref_primary_10_36660_abc_20220369 crossref_primary_10_3390_ijms24119642 crossref_primary_10_1007_s40520_021_01942_8 crossref_primary_10_1002_clc_23970 crossref_primary_10_1007_s41999_024_00950_x crossref_primary_10_1536_ihj_24_378 crossref_primary_10_3390_jcm12185927 crossref_primary_10_3389_fnut_2025_1472596 crossref_primary_10_1186_s12872_023_03632_x crossref_primary_10_1002_ehf2_14392 crossref_primary_10_36660_abc_20230689 crossref_primary_10_1007_s13105_024_01049_4 crossref_primary_10_1136_openhrt_2022_001965 crossref_primary_10_33667_2087_5631_2024_54_47_52 crossref_primary_10_3390_app142411772 crossref_primary_10_1016_j_jamda_2024_105350 crossref_primary_10_3389_fcvm_2023_1232054 crossref_primary_10_1136_bmjopen_2022_066331 crossref_primary_10_1007_s41999_024_01054_2 crossref_primary_10_1007_s00431_023_05410_5 crossref_primary_10_3389_fcvm_2023_1149065 crossref_primary_10_37489_2588_0519_2024_4_113_119 crossref_primary_10_1002_jcsm_13309 crossref_primary_10_1161_CIRCULATIONAHA_123_064071 crossref_primary_10_26724_2079_8334_2023_3_85_91_96 crossref_primary_10_18087_cardio_2024_7_n2637 crossref_primary_10_3390_medicina58121768 crossref_primary_10_1161_CIRCHEARTFAILURE_122_009518 crossref_primary_10_1186_s12872_024_03887_y crossref_primary_10_1111_ggi_14498 crossref_primary_10_53886_gga_e0000146_EN crossref_primary_10_5582_bst_2023_01130 crossref_primary_10_57582_IJBF_240402_072 crossref_primary_10_1007_s11357_023_00777_7 crossref_primary_10_1111_1756_185X_70100 crossref_primary_10_15829_1728_8800_2022_3451 crossref_primary_10_1016_j_pdpdt_2025_104549 crossref_primary_10_1016_j_cardfail_2025_01_028 crossref_primary_10_2147_CIA_S440967 crossref_primary_10_3390_jcm12062305 crossref_primary_10_31083_j_rcm2409273 crossref_primary_10_15420_cfr_2022_29 crossref_primary_10_1002_ehf2_14667 crossref_primary_10_2174_1381612829666230217145100 crossref_primary_10_3390_jcm13030885 crossref_primary_10_1007_s40520_023_02393_z crossref_primary_10_3389_fnut_2024_1431036 crossref_primary_10_1002_jcsm_12954 crossref_primary_10_1186_s43044_024_00484_4 crossref_primary_10_1108_SASBE_01_2022_0009 crossref_primary_10_1159_000536465 crossref_primary_10_3390_app14209218 crossref_primary_10_3390_ijms232214415 crossref_primary_10_1016_j_exger_2024_112631 crossref_primary_10_1186_s12877_023_03784_7 crossref_primary_10_3389_fpubh_2023_1081843 crossref_primary_10_1177_10784535241239684 crossref_primary_10_2174_0118749445288299240116092245 crossref_primary_10_3390_diagnostics15010087 crossref_primary_10_1016_j_ajpc_2021_100247 crossref_primary_10_3390_jcm13164873 crossref_primary_10_1002_ehf2_15044 crossref_primary_10_1016_j_asjsur_2023_12_118 crossref_primary_10_7475_kjan_2023_35_4_303 crossref_primary_10_3390_nu16172853 crossref_primary_10_1016_j_ajcnut_2024_10_010 crossref_primary_10_21886_2712_8156_2024_5_4_39_46 crossref_primary_10_1016_j_jamda_2023_10_035 crossref_primary_10_3389_fpubh_2023_1106458 crossref_primary_10_4070_kcj_2024_0089 crossref_primary_10_1016_j_arr_2022_101739 crossref_primary_10_1007_s00380_022_02046_7 crossref_primary_10_3390_nu17020282 crossref_primary_10_1186_s12872_022_02804_5 crossref_primary_10_1111_ggi_14840 crossref_primary_10_1155_2024_3018760 crossref_primary_10_1097_HCR_0000000000000872 |
| Cites_doi | 10.1097/MCO.0b013e32832cdb0f 10.1016/j.ijcard.2016.04.128 10.1007/s13539-014-0161-y 10.1016/j.jacc.2007.02.037 10.1016/j.biocel.2013.04.025 10.1093/gerona/glu010 10.1016/j.jamda.2013.08.015 10.1161/01.CIR.0000085166.44904.79 10.1152/jappl.1997.83.4.1291 10.1002/jcsm.12268 10.1002/jcsm.12193 10.1016/j.jchf.2017.06.013 10.1016/j.ijcard.2016.07.135 10.1038/s41574-018-0062-9 10.33879/AMH.2019.1809 10.1007/s00508-016-1112-8 10.1093/ageing/afy169 10.1093/eurheartj/ehs381 10.3390/nu12010211 10.1093/geronj/38.6.673 10.2174/1871530311313010008 10.1016/j.jjcc.2019.07.002 10.1093/ageing/afq034 10.1016/j.jamda.2016.09.006 10.1002/ehf2.12237 10.1536/ihj.17-057 10.1002/ejhf.1304 10.1002/ehf2.12545 10.1038/ijo.2009.130 10.1007/s13539-010-0013-3 10.1016/j.comppsych.2015.05.001 10.1067/mem.2002.121483 10.1093/eurheartj/suz234 10.1093/gerona/glp097 10.1016/j.nut.2008.11.023 10.1007/s11357-012-9423-9 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. – notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1002/ehf2.13255 |
| DatabaseName | Wiley-Blackwell Open Access Titles CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley-Blackwell Open Access Titles url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Sarcopenia in heart failure |
| EISSN | 2055-5822 |
| EndPage | 1017 |
| ExternalDocumentID | oai_doaj_org_article_86d781c34b5442568ebecb89d63fa90f PMC8006658 33576177 10_1002_ehf2_13255 EHF213255 |
| Genre | reviewArticle Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GrantInformation_xml | – fundername: Science and Technology Planning Project of Shenzhen City, Guangdong Province, China funderid: SZGW2018002; JCYJ20180703145202065 – fundername: Sanming Project of Medicine in Shenzhen funderid: SZSM201811093 – fundername: Shenzhen Medical Key Discipline Construction Fund – fundername: Science and Technology Planning Project of Shenzhen City, Guangdong Province, China grantid: SZGW2018002; JCYJ20180703145202065 – fundername: Sanming Project of Medicine in Shenzhen grantid: SZSM201811093 |
| GroupedDBID | 0R~ 1OC 24P 53G 5VS 7X7 8FI 8FJ AAHHS ABUWG ACCFJ ACCMX ACXQS ADBBV ADKYN ADZMN ADZOD AEEZP AEQDE AFKRA AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK EBS EJD EMOBN FYUFA GODZA GROUPED_DOAJ HMCUK HYE IAO IHR INH ITC KQ8 M~E OK1 PIMPY PQQKQ PROAC RPM UKHRP WIN AAYXX CITATION PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c6085-7c9b0925e647938383ed3fd6a1afbbd8d24ac015fc3ed5d8415e84543ba765783 |
| IEDL.DBID | 7X7 |
| ISSN | 2055-5822 |
| IngestDate | Wed Aug 27 01:29:03 EDT 2025 Thu Aug 21 18:17:40 EDT 2025 Sun Aug 24 04:04:30 EDT 2025 Mon Jul 14 10:38:05 EDT 2025 Fri Jul 25 06:05:57 EDT 2025 Mon Jul 21 06:02:08 EDT 2025 Tue Jul 01 01:34:55 EDT 2025 Thu Apr 24 23:08:14 EDT 2025 Wed Jan 22 16:31:07 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Heart failure Sarcopenia Muscle wasting Meta-analysis Multimorbidity |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6085-7c9b0925e647938383ed3fd6a1afbbd8d24ac015fc3ed5d8415e84543ba765783 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| ORCID | 0000-0002-9901-0940 0000-0002-4407-6686 0000-0001-5727-8191 |
| OpenAccessLink | https://www.proquest.com/docview/2506246835?pq-origsite=%requestingapplication% |
| PMID | 33576177 |
| PQID | 2506246835 |
| PQPubID | 4368362 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_86d781c34b5442568ebecb89d63fa90f pubmedcentral_primary_oai_pubmedcentral_nih_gov_8006658 proquest_miscellaneous_2489253444 proquest_journals_2551442753 proquest_journals_2506246835 pubmed_primary_33576177 crossref_citationtrail_10_1002_ehf2_13255 crossref_primary_10_1002_ehf2_13255 wiley_primary_10_1002_ehf2_13255_EHF213255 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | April 2021 |
| PublicationDateYYYYMMDD | 2021-04-01 |
| PublicationDate_xml | – month: 04 year: 2021 text: April 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
| PublicationTitle | ESC Heart Failure |
| PublicationTitleAlternate | ESC Heart Fail |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2002; 39 2009; 25 2019; 9 2017; 8 1997; 83 2017; 4 2009; 64 2019; 10 2010; 39 2013; 45 2016; 222 2014; 69 2016; 128 2020; 12 2018; 20 1999; 149 1983; 38 2019; 122 2016; 13 2009; 12 2020; 7 2009; 33 2018; 9 2014; 5 2003; 108 2013; 14 2010; 1 2020; 75 2013; 13 2013; 35 2020 2019; 21 2013; 34 2015; 61 2019; 48 2017 2016; 215 2017; 18 2018; 59 2018; 14 2007; 49 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 Fonseca GWPD (e_1_2_9_22_1) 2019; 122 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_42_1 e_1_2_9_20_1 e_1_2_9_40_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_23_1 e_1_2_9_8_1 Canteri AL (e_1_2_9_13_1) 2019; 9 Collamati A (e_1_2_9_4_1) 2016; 13 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 Zhao W (e_1_2_9_2_1) 2020 e_1_2_9_3_1 Baumgartner RN (e_1_2_9_30_1) 1999; 149 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
| References_xml | – volume: 39 start-page: 131 year: 2002 end-page: 138 article-title: B‐type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea publication-title: Ann Emerg Med – volume: 64 start-page: 1183 year: 2009 end-page: 1189 article-title: Higher inflammatory marker levels in older persons: associations with 5‐year change in muscle mass and muscle strength publication-title: J Gerontol A Biol Sci Med Sci – volume: 128 start-page: 1 year: 2016 end-page: 8 article-title: Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from studies investigating co‐morbidities aggravating heart failure publication-title: Wien Klin Wochenschr – volume: 49 start-page: 1943 year: 2007 end-page: 1950 article-title: Admission B‐type natriuretic peptide levels and in‐hospital mortality in acute decompensated heart failure publication-title: J Am Coll Cardiol – volume: 48 start-page: 16 year: 2019 end-page: 31 article-title: Sarcopenia: revised European consensus on definition and diagnosis publication-title: Age and Agng – volume: 108 start-page: 977 year: 2003 end-page: 982 article-title: Natural history of asymptomatic left ventricular systolic dysfunction in the community publication-title: Circulation – volume: 35 start-page: 1377 year: 2013 end-page: 1385 article-title: Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults—an alternative measurement of sarcopenia and sarcopenic obesity publication-title: Age – volume: 14 start-page: 911 year: 2013 end-page: 915 article-title: Prevalence of sarcopenia in community‐dwelling Japanese older adults publication-title: J Am Med Dir Assoc – volume: 222 start-page: 41 year: 2016 end-page: 46 article-title: Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life publication-title: Int J Cardiol – volume: 12 start-page: 211 year: 2020 article-title: Sarcopenia and heart failure publication-title: Nutrients – volume: 215 start-page: 301 year: 2016 end-page: 306 article-title: A simple sarcopenia screening test predicts future adverse events in patients with heart failure publication-title: Int J Cardiol – volume: 13 start-page: 58 year: 2013 end-page: 67 article-title: Sarcopenia, cachexia and congestive heart failure in the elderly publication-title: Endocr Metab Immune Disord ‐ Drug Targets (Formerly Current Dru) – volume: 69 start-page: 547 year: 2014 end-page: 558 article-title: The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates publication-title: J Gerontol A Biol Sci Med Sci – volume: 122 start-page: 739 year: 2019 end-page: 746 article-title: Sympatho‐vagal imbalance is associated with sarcopenia in male patients with heart failure publication-title: Arq Bras Cardiol – start-page: 1 year: 2020 end-page: 6 article-title: The role of sarcopenia questionnaires in hospitalized patients with chronic heart failure publication-title: Aging Clin Exp Res – volume: 25 start-page: 613 year: 2009 end-page: 619 article-title: Changes in body composition and its relation to muscle strength in 75‐year‐old men and women: a 5‐year prospective follow‐up study of the NORA cohort in Göteborg, Sweden publication-title: Nutrition – volume: 39 start-page: 412 year: 2010 end-page: 423 article-title: Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people publication-title: Age Ageing – volume: 20 start-page: 1580 year: 2018 end-page: 1587 article-title: Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) publication-title: Eur J Heart Fail – volume: 18 start-page: 240 year: 2017 end-page: 245 article-title: Sarcopenia and endothelial function in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA‐HF) publication-title: J Am Med Dir Assoc – volume: 33 start-page: 885 year: 2009 end-page: 892 article-title: Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean Sarcopenic Obesity Study publication-title: Int J Obes (Lond) – volume: 7 start-page: 84 year: 2020 end-page: 91 article-title: Discriminating sarcopenia in overweight/obese male patients with heart failure: the influence of body mass index publication-title: ESC Heart Fail – start-page: 763 year: 2017 end-page: 771 article-title: Heart failure with mid‐range (borderline) ejection fraction: clinical implications and future directions publication-title: Jacc Heart Failure – volume: 13 start-page: 615 year: 2016 end-page: 624 article-title: Sarcopenia in heart failure: mechanisms and therapeutic strategies publication-title: J Geriatr Cardiol – volume: 12 start-page: 384 year: 2009 end-page: 391 article-title: Nutrition in heart failure: an update publication-title: Curr Opin Clin Nutr Metab Care – volume: 59 start-page: 143 year: 2018 end-page: 148 article-title: Significance of sarcopenia evaluation in acute decompensated heart failure publication-title: Int Heart J – volume: 149 start-page: 1161 year: 1999 end-page: 1161 article-title: Epidemiology of sarcopenia among the elderly in New Mexico (vol 147, pg 755, 1998) publication-title: Am J Epidemiol – volume: 14 start-page: 513 year: 2018 end-page: 537 article-title: Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies publication-title: Nat Rev Endocrinol – volume: 21 start-page: L1 year: 2019 end-page: L3 article-title: Introduction to the special issue entitled ‘Heart failure management of the elderly patient: focus on frailty, sarcopenia, cachexia, and dementia’ publication-title: Eur Heart J Suppl – volume: 1 start-page: 187 year: 2010 end-page: 194 article-title: Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) publication-title: J Cachexia Sarcopenia Muscle – volume: 34 start-page: 512 year: 2013 end-page: 519 article-title: Muscle wasting in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) publication-title: Eur Heart J – volume: 75 start-page: 42 year: 2020 end-page: 46 article-title: The difference in determinant factor of six‐minute walking distance between sarcopenic and non‐sarcopenic elderly patients with heart failure publication-title: J Cardiol – volume: 9 start-page: 116 year: 2019 article-title: Sarcopenia in heart failure with reduced ejection fraction publication-title: Am J Cardiovasc Dis – volume: 61 start-page: 78 year: 2015 end-page: 89 article-title: Prevalence of suicide attempts among chinese adolescents: a meta‐analysis of cross‐sectional studies publication-title: Compr Psychiatry – volume: 5 start-page: 253 year: 2014 end-page: 259 article-title: Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014 publication-title: J Cachexia Sarcopenia Muscle – volume: 4 start-page: 492 year: 2017 end-page: 498 article-title: Muscle wasting and sarcopenia in heart failure and beyond: update 2017 publication-title: Esc Heart Failure – volume: 45 start-page: 2257 year: 2013 end-page: 2265 article-title: Muscle wasting in heart failure: an overview publication-title: Int J Biochem Cell Biol – volume: 83 start-page: 1291 year: 1997 end-page: 1299 article-title: Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure publication-title: J Appl Physiol – volume: 10 start-page: 53 year: 2019 end-page: 61 article-title: Sarcopenia predicts adverse outcomes in an elderly outpatient population with New York Heart Association class II–IV heart failure: a prospective cohort study publication-title: Aging Med Healthcare – volume: 9 start-page: 269 year: 2018 end-page: 278 article-title: Pitfalls in the measurement of muscle mass: a need for a reference standard publication-title: J Cachexia Sarcopenia Muscle – volume: 8 start-page: 542 year: 2017 end-page: 548 article-title: Muscle wasting in young patients with dilated cardiomyopathy publication-title: J Cachexia Sarcopenia Muscle – volume: 38 start-page: 673 year: 1983 end-page: 677 article-title: Age changes in body composition revealed by computed tomography publication-title: J Gerontol – ident: e_1_2_9_6_1 doi: 10.1097/MCO.0b013e32832cdb0f – ident: e_1_2_9_17_1 doi: 10.1016/j.ijcard.2016.04.128 – ident: e_1_2_9_26_1 doi: 10.1007/s13539-014-0161-y – volume: 149 start-page: 1161 year: 1999 ident: e_1_2_9_30_1 article-title: Epidemiology of sarcopenia among the elderly in New Mexico (vol 147, pg 755, 1998) publication-title: Am J Epidemiol – ident: e_1_2_9_38_1 doi: 10.1016/j.jacc.2007.02.037 – ident: e_1_2_9_42_1 doi: 10.1016/j.biocel.2013.04.025 – ident: e_1_2_9_32_1 doi: 10.1093/gerona/glu010 – ident: e_1_2_9_27_1 doi: 10.1016/j.jamda.2013.08.015 – ident: e_1_2_9_37_1 doi: 10.1161/01.CIR.0000085166.44904.79 – ident: e_1_2_9_35_1 doi: 10.1152/jappl.1997.83.4.1291 – ident: e_1_2_9_15_1 doi: 10.1002/jcsm.12268 – volume: 13 start-page: 615 year: 2016 ident: e_1_2_9_4_1 article-title: Sarcopenia in heart failure: mechanisms and therapeutic strategies publication-title: J Geriatr Cardiol – ident: e_1_2_9_24_1 doi: 10.1002/jcsm.12193 – ident: e_1_2_9_36_1 doi: 10.1016/j.jchf.2017.06.013 – ident: e_1_2_9_8_1 doi: 10.1016/j.ijcard.2016.07.135 – ident: e_1_2_9_33_1 doi: 10.1038/s41574-018-0062-9 – ident: e_1_2_9_20_1 doi: 10.33879/AMH.2019.1809 – volume: 122 start-page: 739 year: 2019 ident: e_1_2_9_22_1 article-title: Sympatho‐vagal imbalance is associated with sarcopenia in male patients with heart failure publication-title: Arq Bras Cardiol – start-page: 1 year: 2020 ident: e_1_2_9_2_1 article-title: The role of sarcopenia questionnaires in hospitalized patients with chronic heart failure publication-title: Aging Clin Exp Res – ident: e_1_2_9_25_1 doi: 10.1016/j.ijcard.2016.04.128 – ident: e_1_2_9_5_1 doi: 10.1007/s00508-016-1112-8 – ident: e_1_2_9_12_1 doi: 10.1093/ageing/afy169 – ident: e_1_2_9_14_1 doi: 10.1093/eurheartj/ehs381 – ident: e_1_2_9_9_1 doi: 10.3390/nu12010211 – ident: e_1_2_9_41_1 doi: 10.1093/geronj/38.6.673 – ident: e_1_2_9_11_1 doi: 10.2174/1871530311313010008 – ident: e_1_2_9_23_1 doi: 10.1016/j.jjcc.2019.07.002 – ident: e_1_2_9_40_1 doi: 10.1093/ageing/afq034 – ident: e_1_2_9_19_1 doi: 10.1016/j.jamda.2016.09.006 – ident: e_1_2_9_10_1 doi: 10.1002/ehf2.12237 – ident: e_1_2_9_21_1 doi: 10.1536/ihj.17-057 – ident: e_1_2_9_18_1 doi: 10.1002/ejhf.1304 – ident: e_1_2_9_7_1 doi: 10.1002/ehf2.12545 – ident: e_1_2_9_31_1 doi: 10.1038/ijo.2009.130 – ident: e_1_2_9_34_1 doi: 10.1007/s13539-010-0013-3 – volume: 9 start-page: 116 year: 2019 ident: e_1_2_9_13_1 article-title: Sarcopenia in heart failure with reduced ejection fraction publication-title: Am J Cardiovasc Dis – ident: e_1_2_9_16_1 doi: 10.1016/j.comppsych.2015.05.001 – ident: e_1_2_9_39_1 doi: 10.1067/mem.2002.121483 – ident: e_1_2_9_3_1 doi: 10.1093/eurheartj/suz234 – ident: e_1_2_9_43_1 doi: 10.1093/gerona/glp097 – ident: e_1_2_9_28_1 doi: 10.1016/j.nut.2008.11.023 – ident: e_1_2_9_29_1 doi: 10.1007/s11357-012-9423-9 |
| SSID | ssj0001561524 |
| Score | 2.4948902 |
| SecondaryResourceType | review_article |
| Snippet | Aims
Sarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to... Sarcopenia has been found to be frequently associated with co-morbidity among patients with heart failure (HF). However, there remain insufficient data to... AimsSarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain insufficient data to... Abstract Aims Sarcopenia has been found to be frequently associated with co‐morbidity among patients with heart failure (HF). However, there remain... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1007 |
| SubjectTerms | Age Body composition Comorbidity Heart failure Heart Failure - complications Heart Failure - epidemiology Hospitalization Humans Meta-analysis Multimorbidity Muscle function Muscle wasting Older people Patients Population Prevalence Review Reviews Sarcopenia Sarcopenia - diagnosis Sarcopenia - epidemiology Sarcopenia - etiology Systematic review |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB5VPSAuiAKF0IKM4AJSaGI7jsON0q5WlcqFVurNGv-pK0GKYHvnEXhGnoSxk4ZdtdALyiXKWEryzTgzE4-_AXglgtPoHWnAN1Upu4AlosfSVahtpHgk5t6Axx_V_FQenTVnK62-Uk3YQA88ALenlW917YS0jST7Ujrd1erOKxGxq2L6-pLPW0mmxv3B5JjkxEfK98J55G8p9Up7-lY8UCbqvym6vF4kuRq8Zu8zuw_3xrCRvR8edws2Qv8A7hyPC-MP4eATGWzqhLVAtuhZalO9ZBEXqej8HUP2h7CZDZtVGPaefQlL_PXjJ47EJI_gdHZ48mFejg0SSqfSpoHWdbbqeBNU-j-m6QheRK-wxmit155LdIRFdCRovCZnHbRspLDYKpqqYhs2-4s-PAFWUyIThLbeV16GVA_luGpqR5mzskLYAl5fgWbcyB6emlh8NgPvMTcJYJMBLuDlNPbrwJlx46j9hP00IvFc5wukfTNq39ym_QJ2rzRnxsn33VBUp7hUFFv-RUxBouSUpxXwYhLTrEpLJdiHi0saIzXhKqSUBTwe7GB6UCEoR6vbtoB2zULW3mRd0i_OM3O3zitduoA32Zb-gY45nM94Pnv6P3Dagbs8FePkkqNd2Fx-uwzPKJpa2ud54vwGDJAc0g priority: 102 providerName: Directory of Open Access Journals – databaseName: Wiley-Blackwell Open Access Titles dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEB5qBfFFrNfUtqzoi0JssrdsxBetPRyEiqCFvoXZS9oDmlPa03d_gr_RX-LsJifHg1WQvITsBJLZmd1vdme_AXgugjPoHfWAV0Uu64A5osfcFWhsS3ikTbUBjz7q6bH8cKJONuDN8ixMzw8xLrhFz0jjdXRwtJf7K9LQcNbyVxRLKXUDbsaztZE5n8tPqxUWggYqVbXlhVK5oqlw5Cfl-6vX12akRNx_Hdr8M2nydzCbZqPJXbgzwEj2tu_3LdgI3T24dTRslN-H95_JgGNlrBmyWcdi2eoFa3EWk9BfM2QrAmfWH15h2Hn2LSzw5_cfOBCVPIDjyeGXg2k-FEzInY6HCCpX26LmKui4XmboCl60XmOJrbXeeC7RkV5aRw3KG5q8g5FKCouVJtcVD2Gzm3fhMbCSApsgjPW-8DLE_CjHtSodRdLaCmEzeLFUWuMGNvFY1OJr0_Mg8yYquEkKzuDZKHvec2hcK_Uu6n6UiLzX6cH84rQZ3Kgx2lemdEJaJWm00SbaoDW116LFumgz2Fn2XDM442VDKE9zqQlr_qWZQKPkFLdl8HRsJi-LWyfYhfkVyUhDehVSygwe9XYwfqgQFLOVVZVBtWYha3-y3tLNzhKTt0k7XyaDl8mW_qGd5nA64elu-3-En8BtHpNwUqrRDmwuLq7CLqGohd1LzvILZpwWZg priority: 102 providerName: Wiley-Blackwell |
| Title | Sarcopenia in heart failure: a systematic review and meta‐analysis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fehf2.13255 https://www.ncbi.nlm.nih.gov/pubmed/33576177 https://www.proquest.com/docview/2506246835 https://www.proquest.com/docview/2551442753 https://www.proquest.com/docview/2489253444 https://pubmed.ncbi.nlm.nih.gov/PMC8006658 https://doaj.org/article/86d781c34b5442568ebecb89d63fa90f |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RVkJcEG8CZWUEF5BCE9txHC6Iwq5WSK0qoNLeLL9CV4Jsabd3fgK_kV_C2PFmu6JUuUTxHOLxjOfh8TcAL5m3UjuLK-CqIueN17nWTue20NK06I-0sTfgwaGYHvNPs2qWEm7nqaxytSfGjdotbMiR76GpFpQLdBjenf7MQ9eocLqaWmhswU6ALgslXfWsXudY0DmoKB9QSemeP2npGwzAws2-S3YowvVf5WP-Wyp52YWNNmhyB24n55G871f7Ltzw3T24eZCOx-_Dxy8otqEf1lyTeUdCs-olafU8lJ6_JZqsYZtJf2WF6M6RH36p__z6rRM8yQM4noy_fpjmqU1CbkW4OlDbxhQNrbwIWTKJj3esdUKXujXGSUe5tsiL1uJA5SSabC95xZnRtUCFZQ9hu1t0_jGQEsMZz6RxrnDch6ooS0VVWoyfhWHMZPBqxTRlE4Z4aGXxXfXox1QFBqvI4AxeDLSnPXLGlVT7gfcDRUC7jh8WZ99UUh4lhatlaRk3Fcc9RsggeUY2TrBWN0Wbwe5q5VRSwXO1Fpj_DKOryClGaxk8H4ZRt8KBie784gJpuES-Ms55Bo96ORh-lDGM1Mq6zqDekJCNmWyOdPOTiN8t43mXzOB1lKVruKPG0wmNb0-un-JTuEVDsU0sKdqF7eXZhX-G3tLSjGCL8qNRVIwR7OyPD48-j2Lm4S9r-hd7 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrQS9IP4JFDACDiCF7tqO4yAhROmutrS7QtBKvQX_pV0JsqXdCnHjEXgSHoonYez8bFeU3qpcongUJeMZzzee8QzAU-aMVNbgDNikG_PMqVgpq2LTVVIXiEeK0BtwNBbDXf5-L9lbgt_NWRifVtmsiWGhtlPj98jX0FQLygUChjeH32LfNcpHV5sWGpVYbLkf39FlO369uYHz-4zSQX_n3TCuuwrERvhM-9RkupvRxAm_qSTxcpYVVqieKrS20lKuDBrJwuBAYiVaOCd5wplWqUD5ZvjeS7DMGboyHVhe748_fJzv6iAcSShv66DSNXdQ0Jfo8vmzhKcsX2gQcBaq_Tc58zRoDlZvcA2u1nCVvK3k6zosufIGXB7VAfmbsPEJOeI7cE0UmZTEt8eekUJNfLL7K6LIvFA0qQ7JEFVa8tXN1J-fv1RdEOUW7F4IC29Dp5yW7i6QHjpQjkltbddy5_OwDBVJz6DHLjRjOoLnDdNyU1ct980zvuRVvWWaewbngcERPGlpD6taHWdSrXvetxS-vnZ4MD3az2t1zaWwqewZxnXCcVUT0su6lpkVrFBZt4hgtZm5vFb643wuov8ZRnDKKfqHETxuh1GbfYhGlW56gjRcIl8Z5zyCO5UctB_KGPqGvTSNIF2QkIU_WRwpJwehYrgMETYZwYsgS-dwJ-8PBzTc3Tv_Fx_BleHOaDvf3hxv3YcV6lN9QkLTKnRmRyfuAWK1mX5YKwiBzxetk38BnF5RxA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIlVcEP8EChgBB5DSTWzHcZAQArarLaUVElTaW_Bf6EqQLe1WiBuPwPPwODwJY-dnu6L0VuUSxaMoGc94vvGMZwAeM2eksgZnwGZJzAunYqWsik2ipK4Qj1ShN-DOrhjv8beTbLICv7uzMD6tslsTw0JtZ8bvkQ_QVAvKBQKGQdWmRbwfjl4efIt9Bykfae3aaTQisu1-fEf37ejF1hDn-gmlo82Pb8Zx22EgNsJn3eem0ElBMyf8BpPEy1lWWaFSVWltpaVcGTSYlcGBzEq0dk7yjDOtcoGyzvC9F-BizrLU61g-yRf7OwhMMsr7iqh04PYruoHOnz9VeMIGhlYBp-Hbf9M0T8LnYP9GV-ByC1zJq0bSrsKKq6_B2k4bmr8Oww_ID9-La6rItCa-UfacVGrq096fE0UWJaNJc1yGqNqSr26u_vz8pdrSKDdg71wYeBNW61ntbgNJ0ZVyTGprE8udz8gyVGSpQd9daMZ0BE87ppWmrV_u22h8KZvKy7T0DC4DgyN41NMeNFU7TqV67XnfU_hK2-HB7PBz2SpuKYXNZWoY1xnH9U1IL_VaFlawShVJFcF6N3Nlq_5H5UJY_zOMMJVT9BQjeNgPo177YI2q3ewYabhEvjLOeQS3GjnoP5Qx9BLTPI8gX5KQpT9ZHqmn-6F2uAyxNhnBsyBLZ3Cn3ByPaLi7c_YvPoA11MTy3dbu9l24RH3OT8hsWofV-eGxu4egba7vB-0g8Om81fEvmJFUlA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcopenia+in+heart+failure%3A+a+systematic+review+and+meta-analysis&rft.jtitle=ESC+Heart+Failure&rft.au=Zhang%2C+Yan&rft.au=Zhang%2C+Jia&rft.au=Ni%2C+Wenqing&rft.au=Yuan%2C+Xueli&rft.date=2021-04-01&rft.issn=2055-5822&rft.eissn=2055-5822&rft.volume=8&rft.issue=2&rft.spage=1007&rft_id=info:doi/10.1002%2Fehf2.13255&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-5822&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-5822&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-5822&client=summon |